Variant NM_000492.4:c.772A>G
Name | NM_000492.4:c.772A>G |
Protein name | NP_000483.3:p.(Arg258Gly) |
Genomic name (hg19) | chr7:g.117176630A>G UCSC |
#Exon/intron | exon 7 |
Legacy Name | R258G |
Class | disease-causing |
Subclass | CFTR-RD-causing |
WT sequence | TCAGAGAGCTGGGAAGATCAGTGAA A GACTTGTGATTACCTCAGAAATGAT |
Mutant sequence | TCAGAGAGCTGGGAAGATCAGTGAA G GACTTGTGATTACCTCAGAAATGAT |
dbSNP rs191456345 |
Reference | PMID | Splicing | mRNA level | Maturation | Localization | Channel fonction (Cl-) | Bicarbonate |
Seibert et al, 1997 | 9305991 | ✓ | ✓ | ✓ |
« ✓ » indicates the type of analysis performed and not the results
Modulator | FDA approval | EMA approval | in vitro / ex vivo data | clinical data |
IVA | no | no | no | no |
TEZ-IVA | yes | no | yes | no |
ELX-TEZ-IVA | yes | no | yes | no |
clinical and functional data are provided by Vertex
1 individuals carrying this variant are reported in CFTR-NGS catalogue |
TOTAL NUMBER OF PATIENTS | 7 |
---|---|
Asymptomatic compound heterozygote | 1 |
CF | 1 |
CFTR-RD | 4
|
Pending (NBS) | 1 |
Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
Phenotype | Patient ID | Variant status | Additional variants |
---|---|---|---|
CBAVD | 4682 | heterozygote | CF-causing- Undef VUS3- Undef |
CBAVD | 4566 | heterozygote | CF-causing- Undef |
CF | 305 | heterozygote | CF-causing- Undef |
Asymptomatic compound heterozygote | 5513 | heterozygote | CF-causing - Trans |
Pancreatitis | 5892 | heterozygote | CF-causing- Undef |
Bronchiectasis | 4906 | heterozygote | CFTR-RD-causing - Trans |
Pending (NBS) | 6025 | heterozygote | CF-causing - Trans |
Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
CFTR variants are clustered into five groups: |
|